News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McLaughlin Gerald W.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2019 |
4/A
| McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Granted 392,688 options to buy
@ $2.31, valued at
$907.1k
|
|
| 03/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2018 |
4
| McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Bought 17,097 shares
@ $2.1126, valued at
$36.1k
|
|
| 12/07/2018 |
4
| McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Bought 7,403 shares
@ $2.0424, valued at
$15.1k
|
|
| 06/28/2018 |
4
| McLaughlin Gerald W. (CEO) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Granted 600,000 options to buy
@ $6.2, valued at
$3.7M
|
|
| 06/28/2018 |
3
| McLaughlin Gerald W. (CEO) has filed a Form 3 on Neos Therapeutics, Inc. |
| 10/22/2015 |
4
| McLaughlin Gerald W. (Director) has filed a Form 4 on Nemus Bioscience, Inc.|
Txns:
| Granted 30,000 shares
@ $0 |
|
| 08/24/2015 |
4
| McLaughlin Gerald W. (Director) has filed a Form 4 on Nemus Bioscience, Inc.|
Txns:
| Converted 31,250 shares
@ $0
Converted 10,000 preferred shares
@ $0 |
|
| 06/02/2015 |
4
| McLaughlin Gerald W. (Director) has filed a Form 4 on Nemus Bioscience, Inc.|
Txns:
| Bought 10,000 options to buy
@ $2.5, valued at
$25k
Bought 2,000 options to buy
@ $5, valued at
$10k
|
|
| 12/08/2014 |
4
| McLaughlin Gerald W. (Director) has filed a Form 4 on Nemus Bioscience, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0 |
|
| 02/25/2014 |
4
| McLaughlin Gerald W. (SVP, Chief Commercial Officer) has filed a Form 4 on NUPATHE INC.|
Txns:
| Unknown transaction of 11,771 shares
@ $6.8, valued at
$80k
Disposed/sold 144,880 shares
@ $6.8, valued at
$985.2k
Disposed/sold 22,707 options to buy
@ $1.44, valued at
$32.7k
Disposed/sold 57,054 options to buy
@ $1.92, valued at
$109.5k
Disposed/sold 5,988 options to buy
@ $1.92, valued at
$11.5k
|
|
| 01/22/2013 |
4
| McLaughlin Gerald W. (VP, ChiefCommercial Officer) has filed a Form 4 on NUPATHE INC.|
Txns:
| Granted 125,000 shares
@ $0 |
|
| 01/09/2013 |
4
| McLaughlin Gerald W. (VP, ChiefCommercial Officer) has filed a Form 4 on NUPATHE INC.|
Txns:
| Granted 8,109 shares
@ $0
Granted 23,542 shares
@ $0
Disposed/sold 16,219 options to buy
@ $10, valued at
$162.2k
Disposed/sold 32,850 options to buy
@ $3.06, valued at
$100.5k
|
|
| 03/27/2012 |
4
| McLaughlin Gerald W. (VP, Commercial Operations) has filed a Form 4 on NUPATHE INC.|
Txns:
| Granted 32,850 options to buy
@ $3.06, valued at
$100.5k
|
|
| 08/05/2010 |
3
| McLaughlin Gerald W. (VP Commercial Operations) has filed a Form 3 on NUPATHE INC. |
|
|